Eric Cober
Impact in
- Molecular Medicine top 0.1%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antibiotic Resistance in Bacteria 32
-
- Antibiotic Use and Resistance 11
- Co-authors
- David van Duin (24 shared papers)Sandra S. Richter (18 shared papers)Robert A. Bonomo (21 shared papers)Keith S. Kaye (18 shared papers)Robert A. Salata (17 shared papers)Federico Pérez (14 shared papers)Vance G. Fowler (16 shared papers)Scott R. Evans (14 shared papers)
- Journals
- Open Forum Infectious Diseases (7 papers)Antimicrobial Agents and Chemotherapy (7 papers)Clinical Infectious Diseases (4 papers)Journal of Antimicrobial Chemotherapy (3 papers)mBio (2 papers)
- Partner nations
- United StatesChinaJapan
In The Last Decade
Eric Cober
43 papers receiving 2.8k citations
Eric Cober's Hit Papers
Peers
Comparison fields: 5 of 93
- Molecular Medicine 2.0k
- Applied Microbiology and Biotechnology 420
- Endocrinology 322
- Clinical Biochemistry 299
- Pharmacology 591
Countries citing papers authored by Eric Cober
This map shows the geographic impact of Eric Cober's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Cober with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Cober more than expected).
Fields of papers citing papers by Eric Cober
This network shows the impact of papers produced by Eric Cober. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Cober. The network helps show where Eric Cober may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric Cober, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae Hit paper breakdown → | 2017 | 560 |
| 2 | 2020 | 273 | |
| 3 | 2021 | 262 | |
| 4 | Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study Hit paper breakdown → | 2023 | 223 |
| 5 | 2016 | 172 | |
| 6 | 2014 | 150 | |
| 7 | 2011 | 144 | |
| 8 | 2016 | 98 | |
| 9 | 2019 | 87 | |
| 10 | 2023 | 74 | |
| 11 | 2022 | 71 | |
| 12 | 2017 | 71 | |
| 13 | 2014 | 68 | |
| 14 | 2014 | 62 | |
| 15 | 2020 | 57 | |
| 16 | 2015 | 52 | |
| 17 | 2014 | 51 | |
| 18 | 2009 | 40 | |
| 19 | 2014 | 40 | |
| 20 | 2015 | 28 |
About Eric Cober
Eric Cober is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology, Pharmacology, Endocrinology and Epidemiology, having authored 48 papers that have together received 2.9k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (32 papers), Antibiotics Pharmacokinetics and Efficacy (12 papers), Antibiotic Use and Resistance (11 papers), Enterobacteriaceae and Cronobacter Research (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers), Neutropenia and Cancer Infections (3 papers), Antifungal resistance and susceptibility (3 papers) and Urinary Tract Infections Management (2 papers). The work is most often cited by research in Molecular Medicine (2.0k citations), Applied Microbiology and Biotechnology (420 citations), Endocrinology (322 citations), Clinical Biochemistry (299 citations) and Pharmacology (591 citations). Eric Cober has collaborated with scholars based in United States, China and Japan. Frequent co-authors include David van Duin, Sandra S. Richter, Robert A. Bonomo, Keith S. Kaye, Robert A. Salata, Federico Pérez, Vance G. Fowler, Scott R. Evans, Robert C. Kalayjian and Yohei Doi. Their work appears in journals such as Open Forum Infectious Diseases, Antimicrobial Agents and Chemotherapy, Clinical Infectious Diseases, Journal of Antimicrobial Chemotherapy and mBio.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.